Grade: Pharmaceutical Grade

Factory Location: Lianyungang, Jiangsu, China.

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Sample Provided: no

Indacaterol is an ultra-long-acting beta-adrenoceptor agonist. It is for the treatment of chronic obstructive pulmonary disease (COPD) (long-term data in patients with asthma are thus far lacking). It is delivered as an aerosol formulation through a dry powder inhaler.

It is in R&D stage.